- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT05571189
Hjemtrehabilitering etter akutt lungeemboli
The purpose of this study is to evaluate whether a home rehabilitation program after hospitalization for acute pulmonary embolism (PE) improves clinical outcomes at 3 months compared to usual care. Daily physical activity tasks that incorporate heart rate monitoring will be sent through email or text. This information could help improve the management of acute PE.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
New York
-
Rochester, New York, Forente stater, 14642
- University of Rochester Medical Center
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- English speaking (>18 years old). Daily messages will be sent in English.
- Acute PE with right ventricular enlargement or dysfunction defined by echocardiogram report, CT Angiogram report, or elevated cardiac biomarker (NT-pro BNP or troponin).
- Baseline testing started within 7 days of hospital discharge.
Exclusion Criteria:
- Pregnancy.
- Cardiac Effort >2.5 beats/m during 6MWT. This is for safety.
- Cardiac Effort <1.2 beats/m during 6MWT. They are unlikely to benefit.
- Resting tachycardia >120 beats/m during screening or at hospital discharge.
- Suspicion for Chronic Thromboembolic Pulmonary Hypertension.
- Systolic blood pressure >180 mmHg during screening or at hospital discharge.
- Inability to walk.
- Estimated prognosis <12 months at the time of discharge due to underlying co-morbidities.
- Advanced neurologic disease.
- Lack of access to email or text messaging.
- Inability to follow daily instructions.
- Participation in a structured exercise routine at least three days per week in the prior four weeks.
- Principal Investigator discretion
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Participants who receive daily activity message
The intervention group will receive instructions for a daily activity sent through SMS text message or email. |
Participants will receive a text each day with instructions about the daily activity they should complete for that day. |
|
Placebo komparator: Participants who receive control message
The control group will receive daily messages to help with blinding sent through text message or email. The messages will not include activity tasks and will include phrases such as "I hope you have a good day". |
Participants will receive a text each day with no instructions about daily activity. It will have messages like "have a nice day." |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
mean change in vector magnitude count as measured by actigraphy
Tidsramme: 10 weeks
|
The Actigraph triaxial accelerometer will be used to monitor continuous activity at home on the non-dominant wrist. The accelerometer data will be downloaded and will include the vector magnitude count. |
10 weeks
|
|
mean change in mean amplitude deviation as measured by actigraphy
Tidsramme: 10 weeks
|
The Actigraph triaxial accelerometer will be used to monitor continuous activity at home on the non-dominant wrist. The accelerometer data will be downloaded and will include the mean amplitude deviation. |
10 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
bety endring på 6 minutters gangavstand
Tidsramme: 12 uker
|
12 uker
|
|
|
bety endring i hjertefrekvens i løpet av en 6 minutters spasertur
Tidsramme: 12 uker
|
12 uker
|
|
|
andel eller personer som utvikler kronisk tromboembolisk pulmonal hypertensjon
Tidsramme: 12 uker
|
12 uker
|
|
|
proportion of participants with post-PE syndrome
Tidsramme: 12 weeks
|
Participants will be evaluated by a physician to determine if they have post PE-syndrome |
12 weeks
|
|
mean change in steps as measured by Actigraph
Tidsramme: 12 weeks
|
The Actigraph triaxial accelerometer will be used to monitor the number of steps taken at home on the non-dominant wrist. The accelerometer data will be downloaded and will include the step count. |
12 weeks
|
|
mean change in activity as measured by Actigraph
Tidsramme: 12 weeks
|
The Actigraph triaxial accelerometer will be used to monitor the amount of activity taken at home on the non-dominant wrist. The accelerometer data will be downloaded and will include the amount of activity. |
12 weeks
|
|
mean change in quality of life as measured by PROMIS
Tidsramme: 12 weeks
|
The PROMIS questionnaire ranges from 0-99 with higher scores indicating worse outcome. |
12 weeks
|
|
mean change in quality of life as measured by Emphasis 10
Tidsramme: 12 weeks
|
The Emphasis 10 questionnaire ranges from 0-50 with higher scores indicating worse quality of life. |
12 weeks
|
|
mean change in quality of life as measured by Pulmonary Embolism quality of life questionnaire
Tidsramme: 12 weeks
|
The pulmonary embolism quality of life questionnaire ranges from 1 to 27 with higher scores indicating worse outcomes. |
12 weeks
|
|
mean change in oxygen use during a 6 minute walk
Tidsramme: 12 weeks
|
Oxygen use will be measured by a measured by portable K5 metabolic analyzer. |
12 weeks
|
|
mean change in carbon dioxide production during a 6 minute walk
Tidsramme: 12 weeks
|
Carbon Dioxide use will be measured by a measured by portable K5 metabolic analyzer. |
12 weeks
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Daniel Lachant, DO, University of Rochester
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- STUDY00007680
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .